A PYMNTS Company

US: BioTelemetry gains HSR clearance

By  |  May 8, 2017

BioTelemetry announced on Monday that on May 5, 2017, it received early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to its previously announced tender offer to acquire all of the capital stock of LifeWatch AG. This clearance comes without any condition on or undertaking by BioTelemetry, LifeWatch or any of their respective subsidiaries.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The expiration of the HSR waiting period satisfies one of the closing conditions of the pending tender offer, which remains subject to other closing conditions as described in the prospectus for the offer published by BioTelemetry on April 24, 2017. Subject to the satisfaction of the other conditions, BioTelemetry expects the transaction to close in the third quarter of 2017.

    According to the current timetable, the main offer period starts on May 10, 2017 and is expected to end on May 23, 2017, subject to any extension of the offer period.

    Full Content: Globe Newswire

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.